The cancer metabolic reprogramming and immune response
2021 · Molecular Cancer · 1,236 citations
https://doi.org/10.1186/s12943-021-01316-8
M
Min Su
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
4.6K
Citations
29
h-index
48
i10-index
Min Su is an academic researcher from Central South University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA modifications and cancer & MicroRNA in disease regulation. The author has an h-index of 29, co-authored 63 publications.
ORCID: 0000-0001-8871-1883Papers by this author
worksCircular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers
2019 · Molecular Cancer · 525 citations
https://doi.org/10.1186/s12943-019-1002-6
Targeting EphA2 in cancer
2020 · Journal of Hematology & Oncology · 223 citations
https://doi.org/10.1186/s13045-020-00944-9
AKT and ERK dual inhibitors: The way forward?
2019 · Cancer Letters · 211 citations
https://doi.org/10.1016/j.canlet.2019.05.025
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity
2022 · Oncogene · 121 citations
https://doi.org/10.1038/s41388-021-02148-y
The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4
2016 · Scientific Reports · 81 citations
https://doi.org/10.1038/srep28139
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat